HRS 2024: Vektor Medical's vMap Technology to be Highlighted in Rhythm Theater and Eight Posters

Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology, today unveiled a comprehensive schedule of educational content and sessions featuring the use of vMap^® at this year's Heart Rhythm 2024 conference in Boston, May 16-19.

vMap rapidly provides actionable arrhythmia localization insights for physicians. The research and presentations at HRS further demonstrate the unique ability of vMap to assist physicians with both focal and fibrillation-type arrhythmias. Attendees can experience vMap at the Vektor Medical booth (#669), hear expert perspectives from leading KOLs during the Rhythm Theater, and read more about vMap in various scientific posters and presentations. Details follow:

"The Future of Care: Leveraging AI for Arrhythmia Localization"
Rhythm Theater Symposium | Friday, May 17 | 4:00 ? 5:00 p.m.

Discover how vMap integrates intelligently into existing workflows, elevating patient care and streamlining procedures. An expert panel including Drs. Gery Tomassoni, Ulrika Birgersdotter-Green, Jag Singh, Ben D'Souza, John Miller, and David Krummen will discuss the transformative power of AI-driven ECG analysis, shaping the future of ablations, enhancing efficiencies, and optimizing outcomes.

Scientific Posters and Abstract Presentations

Friday, May 17

• Outcomes of Non-Invasive Artificial Intelligence-based CT and ECG Mapping to Guide Concomitant Surgical Ablation of Ventricular Tachycardia at Time of LVAD Implantation
  PO-01-147
  Lead Author: Gordon Ho, MD, et al.
  10:30 a.m. ? 12:30 p.m. | Abstract Pavilion - BCEC

• A Novel Machine Learning Algorithm Provides Greater Accuracy than Visual ECG-based Criteria for Localizing Endocardial vs Epicardial Activation of the Left Ventricle
  MP-470548-005
  Presenting Author: Erin Dressens, DO
  4:15 ? 4:20 p.m. | Moderated Poster Hub 2 - BCEC

Saturday, May 18

• Forward Solution Machine Learning ECG Mapping to Guide Remote Magnetic Navigation Catheter Ablation in a Patient with Polymorphic Ventricular Tachycardia
  PO-04-197
  Lead Author: David E. Krummen, MD, et al.
  10:30 a.m. ? 12:30 p.m. | Abstract Pavilion - BCEC

Sunday, May 19

• Non-Invasive Co-Localization of Ventricular Tachycardia Isthmuses and Scar Using Integrated Artificial Intelligence-Based CT and ECG Analysis
  PO-06-120
  Lead Author: Gordon Ho, MD, et al.
  9:30 ? 11:30 a.m. | Abstract Pavilion - BCEC

• Clinical Outcomes of Prospective Computational 12-Lead ECG Mapping Guided PVC Ablation
  PO-06-117
  Lead Author: Kevin Sung, MD, MS, et al.
  9:30 ? 11:30 a.m. | Abstract Pavilion ? BCEC

• Feasibility of Localizing the VT Isthmus Using AI-based CT and ECG Mapping in the Presence of an LV Assist Device
  PO-06-199
  Lead Author: Gordon Ho, MD, et al.
  9:30 ? 11:30 a.m. | Abstract Pavilion ? BCEC

• Successful Stereotactic Radioablation of Calcified Epicardial Ventricular Tachycardia Guided by Novel Non-Invasive Artificial Intelligence-Based CT and 12-Lead ECG Mapping
  PO-06-196
  Lead Author: Mitchell Wong, et al.
  9:30 ? 11:30 a.m. | Abstract Pavilion ? BCEC

"HRS is a vital opportunity for us to connect with the electrophysiology community, share our latest data, and receive invaluable feedback," said Rob Krummen, CEO of Vektor Medical. "Our team is deeply committed to advancing cardiac care, and I'm excited to see how vMap continues to improve patient outcomes and streamline procedures. Our program of activities at HRS illustrates the transformative power of vMap, both in tangible clinical results and the broader, intangible benefits it brings to the healthcare landscape."

For more information about vMap or to meet with Vektor Medical at HRS 2024, please visit booth 669, contact us here, and connect on LinkedIn.

About vMap®

vMap is the only FDA-cleared, non-invasive AI-based solution for mapping arrhythmias, utilizing just a 12-lead ECG. vMap localizes arrhythmia sources for focal and fibrillation-type arrhythmias, including atrial fibrillation. By unlocking actionable insights contained within a standard 12-lead ECG, vMap enables physicians to rapidly and accurately locate arrhythmia source locations. Backed by extensive clinical evidence, vMap not only improves patient outcomes but also reduces procedure time, optimizing workflow across the entire arrhythmia care pathway.

About Vektor Medical

Headquartered in San Diego, Vektor Medical is on a mission to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Through its AI-based, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. For more information about vMap and Vektor Medical, please visit www.vektormedical.com.

Follow Vektor Medical: LinkedIn and Twitter/X.